Seres Therapeutics Inc To Highlight Opportunities For Microbiome Therapeutics In Infection Protection Call Transcript
Good day, and welcome to the Seres Therapeutics Investor Event. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to turn the call over to Carlo Tanzi of Investor Relations. You may begin.
Good morning to everyone on the webcast, and welcome to Seres Therapeutics Infection Prevention Investor Event. We have posted accompanying slides to Seres website, and I encourage you to view those during the presentation. Following our prepared remarks, we will open the call up for a question-and-answer session. We expect today's event to be about 1 hour in duration.
Before we get started, I'd like to remind you that we'll be making forward-looking statements, including, but not limiting to, our development plans and the promise and potential impact of microbiome therapeutics in preventing infection as well as others described on Slide 2 in our presentation. These statements are subject to certain risks and uncertainties, which are discussed under the Risk Factors
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |